Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a patient’s genetic makeup to customize the medications they receive. Pharmacogenomics promises to offer a more customized (or exact) approach to the use of readily available medications in treating patients in this way. Polymerase chain reaction, deoxyribonucleic acid sequencing, microarray, electrophoresis, and mass spectrometry are only a few of the technologies used in pharmacogenomics. Pharmacogenomics uses genetic testing to assess the effectiveness of recently produced medications as well as the likelihood that a patient would develop a particular disease.
The Global Pharmacogenomics Market size was valued at USD 13.1 billion in 2021 and is expected to grow by USD 33.1 billion in 2030 at a CAGR of 11.1%.
Request Sample PDF of the Report: https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Furthermore, the pharmacogenomics market is also anticipated to increase during the projected period due to technical developments connected to molecular diagnostics procedures for a better knowledge of the genetic makeup of the particular patients.
The Pharmacogenomics market has several key players operating in the industry:
Prominent Companies to Establish Various Corporate Strategies to Aid in Global Expansion. These players are focusing on strategic collaborations and partnerships to expand their market presence and strengthen their product portfolio.
Key Player are covered:
- Admera Health
- Abbott Laboratories.
- Agilent Technologies
- Novartis AG
- Dynamic DNA Laboratories
- Empire Genomics, LLC.
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- OneOme, LLC
- Myriad Genetics Inc.
- OPKO Health, Inc. (GeneDx.)
- Thermo Fisher Scientific, Inc.
- AltheaDx
SEGMENTATION: The market is segmented based on product type, application, end-user, and region.
By Technology
- DNA Sequencing
- Microarray
- Polymerase Chain Reaction
- Electrophoresis
By Application
- Drug Discovery
- Neurology
- Oncology
Inquire Before Buying This Report: https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Regional Outlook:
- North America
- Middle East and Africa
- Asia-Pacific
- Europe
- South America
Why Purchase the Report?
- The report includes information such as market dynamics scenario, opportunities and challenges during the forecast period
- Identify the key regulations prevailing in the market and understand their impact on the market over the forecast period
- Regional, sub-regional, and country-level data include the demand and supply forces along with their influence on the market.
- The competitive landscape comprises a share of key players, offering products, relevant financial information, recent developments, SWOT analysis, and strategies.
- Understand the current market scenario and viability of the global market over the forecast period.
Browse Complete Report @ https://www.extrapolate.com/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
Some of the key questions answered in this report:
- What can we estimate about the anticipated growth rates and also the global egg donation industry size by 2030?
- What will happen in the coming existing and emerging markets?
- What will the market development pace of market?
- Which are the five top players in the egg donation market?
- How will the egg donation market change in the upcoming years?
KEY INDUSTRY DEVELOPMENTS:
- In September 2021, Abbott, a U.S. multinational medical products and health care corporation acquired the Walk Vascular, LLC, a commercial-stage medical device startup with a minimally invasive mechanical aspiration thrombectomy system intended to remove peripheral blood clots.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. COVID-19 Impact On Pharmacogenomics Market
Chapter 5. Global Pharmacogenomics Market Overview, By Type, 2017 – 2030(USD Million)
———Continued
Browse Complete TOC: https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/pharmacogenomics-market/25959
KEY INDUSTRY DEVELOPMENTS:
February 2021- Virtus Health has collaborated with CooperSurgical to improve digital platforms for reproductive services. This will allow firm to integrate innovative technologies in fertility treatments.
About Extrapolate
Extrapolate is a Global Market Research, Advisory and Consulting firm which works closely with Industry experts from various industries to bring the latest and most accurate research reports.In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets – not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.
Contact Us
Extrapolate
Phone: (+1) 888 328 2189
E-mail: [email protected]
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog